During Wednesday’s House subcommittee hearing on insulin price hikes, drug makers and benefits managers pointed fingers at each other for the last decade’s 300% price increase, frustrating congressional representatives.
Category: Kaiser Health News
Podcast: KHN’s ‘What The Health’ The GOP’s Health Reform Whiplash
Rebecca Adams of CQ Roll Call, Anna Edney of Bloomberg News and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss the latest “will they or won’t they?” when it comes to Republicans and comprehensive health reform. Also, a wrap-up of the latest abortion fights in the states and on Capitol Hill. And, another court setback for the Trump administration’s efforts to undermine the Affordable Care Act. Plus, Rovner interviews KHN’s Paula Andalo about the latest “Bill of the Month” feature.
Popular Weed Killer’s Alleged Link To Cancer Spreads Concern
The main ingredient in numerous popular herbicides has been implicated by two juries in the cancers of frequent users, but major public health agencies disagree over whether it is a carcinogen. Can you use it safely in your garden? Here are some answers to questions you may have about the weed killer glyphosate.